Drug Trial Radar · NCT04688320
Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE
Last checked: Nov 20, 2026Latest source record: Apr 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
310
Actual
Start
Dec 15, 2020
Primary completion
Jul 27, 2023
Study completion Jul 27, 2023
Sponsor
- Lead sponsor
- Supergene, LLCIndustry
- Sponsor type
- Industry
- First posted
- Dec 29, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Objective: to evaluate the efficacy and safety of the Recombinant Non-immunogenic Staphylokinase with its single bolus administration in comparison with the bolus-infusion administration of the Alteplase in patients with massive pulmonary embolism
Conditions
- Massive Pulmonary Embolism
Interventions
Recombinant nonimmunogenic staphylokinaseDrug
15 mg of drug reconstituted in 10 ml of 0.9% solution of NaCl given as single i.v. bolus over 10-15 seconds
AlteplaseDrug
Alteplase® is administered in accordance with the instructions for use for pulmonary embolism ( 10 mg bolus and 90 mg as IV infusion over 2 hours, maximum 100 mg). In patients weighing less than 65 kg, the total dose should not exceed 1.5 mg / kg.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Death From All CausesTime frame: within 7 days
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Belgorod Regional Clinical Hospital of St. Joseph
Belgorod, Russia
Kuzbass Cardiology center
Kemerovo, Russia
Krasnoyarsk Regional Clinical Hospital
Krasnoyarsk, Russia
Kursk Regional Clinical Hospital
Kursk, Russia
D.D. Pletnev City Clinical Hospital
Moscow, Russia
I.V. Davydovskii City Clinical Hospital
Moscow, Russia
S.S. Yudin City Clinical Hospital
Moscow, Russia
V.V. Vinogradov City Clinical Hospital
Moscow, Russia
V.V. Veresaev City Clinical Hospital
Moscow, Russia
N.V. Sklifosovsky Research Institute for Emergency Medicine
Moscow, Russia
S.P. Botkin City Clinical Hospital
Moscow, Russia
Murmansk Regional Clinical Hospital
Murmansk, Russia
N.N. Burdenko Penza Regional Clinical hospital
Penza, Russia
G.A. Zakharyin Clinical hospital №6
Penza, Russia
Saint Petersburg "Mariinskaya" City Hospital
Saint Petersburg, Russia
Holy Martyr Elizabeth Saint Petersburg City Hospital
Saint Petersburg, Russia
V.P. Polyakov Samara Regional Clinical Cardiology Dispensary
Samara, Russia
Saratov Regional Clinical Cardiology Dispensary
Saratov, Russia
Tver Regional Clinical Hospital
Tver', Russia
City Clinical hospital №4
Vladimir, Russia
City Clinical Hospital of Emergency №25
Volgograd, Russia
V.F. Dolgopolov Vyselki Central District Hospital
Vyselki, Krasnodarskiy Kray, Russia
Sergiyev Posad Regional Clinical Hospital
Sergiyev Posad, Moscow Oblast, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.